NMR-Based Screening for Inborn Errors of Metabolism: Initial Results from a Study on Turkish Neonates.

Approximately 1 in 400 neonates in Turkey is affected by inherited metabolic diseases. This high prevalence is at least in part due to consanguineous marriages. Standard screening in Turkey now covers only three metabolic diseases (phenylketonuria, congenital hypothyroidism, and biotinidase deficiency). Once symptoms have developed, tandem-MS can be used, although this currently covers only up to 40 metabolites. NMR potentially offers a rapid and versatile alternative.We conducted a multi-center clinical study in 14 clinical centers in Turkey. Urine samples from 989 neonates were collected and investigated by using NMR spectroscopy in two different laboratories. The primary objective of the present study was to explore the range of variation of concentration and chemical shifts of specific metabolites without clinically relevant findings that can be detected in the urine of Turkish neonates. The secondary objective was the integration of the results from a healthy reference population of neonates into an NMR database, for routine and completely automatic screening of congenital metabolic diseases.Both targeted and untargeted analyses were performed on the data. Targeted analysis was aimed at 65 metabolites. Limits of detection and quantitation were determined by generating urine spectra, in which known concentrations of the analytes were added electronically as well as by real spiking. Untargeted analysis involved analysis of the whole spectrum for abnormal features, using statistical procedures, including principal component analysis. Outliers were eliminated by model building. Untargeted analysis was used to detect known and unknown compounds and jaundice, proteinuria, and acidemia. The results will be used to establish a database to detect pathological concentration ranges and for routine screening.

[1]  U. Engelke,et al.  Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism , 2003, Annals of clinical biochemistry.

[2]  C. Scott.  The genetic tyrosinemias , 2006, American journal of medical genetics. Part C, Seminars in medical genetics.

[3]  Eric R. Ziegel,et al.  Handbook of Chemometrics and Qualimetrics, Part B , 2000, Technometrics.

[4]  Eric R. Ziegel,et al.  The Elements of Statistical Learning , 2003, Technometrics.

[5]  R. D. De Abreu,et al.  1H-NMR spectroscopy of body fluids: inborn errors of purine and pyrimidine metabolism. , 1999, Clinical chemistry.

[6]  Heymut Omran,et al.  NMR spectroscopy of aminoacylase 1 deficiency, a novel inborn error of metabolism , 2008, NMR in biomedicine.

[7]  Ara W. Darzi,et al.  Metabolic phenotyping in clinical and surgical environments , 2012, Nature.

[8]  E Holmes,et al.  750 MHz 1H NMR spectroscopy characterisation of the complex metabolic pattern of urine from patients with inborn errors of metabolism: 2-hydroxyglutaric aciduria and maple syrup urine disease. , 1997, Journal of pharmaceutical and biomedical analysis.

[9]  J. Leonard,et al.  Diagnosis and early management of inborn errors of metabolism presenting around the time of birth. , 2006, Acta paediatrica.

[10]  Robert Tibshirani,et al.  The Elements of Statistical Learning: Data Mining, Inference, and Prediction, 2nd Edition , 2001, Springer Series in Statistics.

[11]  A. Pomerantsev.  Acceptance areas for multivariate classification derived by projection methods , 2008 .

[12]  Donald H Chace,et al.  A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing. , 2005, Clinical biochemistry.

[13]  R. Chalmers,et al.  High-resolution 1H-NMR spectroscopy of blood plasma for metabolic studies. , 1995, Clinical chemistry.

[14]  F. Sedel,et al.  Clinical approach to treatable inborn metabolic diseases: An introduction , 2006, Journal of Inherited Metabolic Disease.

[15]  Johanna Smeyers-Verbeke,et al.  Handbook of Chemometrics and Qualimetrics: Part A , 1997 .

[16]  Edoardo Saccenti,et al.  Individual human phenotypes in metabolic space and time. , 2009, Journal of proteome research.

[17]  D. Danks,et al.  Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria. , 2000, Molecular genetics and metabolism.

[18]  C. Greenberg,et al.  LC-MS/MS progress in newborn screening. , 2011, Clinical biochemistry.

[19]  A. Heerschap,et al.  High-resolution 1H-NMR spectroscopy of blood plasma for metabolic studies. , 1994, Clinical chemistry.

[20]  Ivano Bertini,et al.  Evidence of different metabolic phenotypes in humans , 2008, Proceedings of the National Academy of Sciences.

[21]  M. Durán,et al.  Physician’s Guide to the Laboratory Diagnosis of Metabolic Diseases , 2003, Springer Berlin Heidelberg.

[22]  Habshah Midi,et al.  High breakdown estimators to robustify phase II multivariate control charts. , 2011 .